SEC Comment Letter 0000000000-23-005453 to ENZO BIOCHEM INC (ENZ) (CIK 0000316253)
ENZO BIOCHEM INC (ENZ) (CIK 0000316253)
Date: May 22, 2023 · CIK: 0000316253 · Accession: 0000000000-23-005453
AI Filing Summary & Sentiment
File numbers found in text: 333-271911
Letter
United States securities and exchange commission logo May 22, 2023 Hamid Erfanian Chief Executive Officer Enzo Biochem, Inc. 81 Executive Blvd., Suite 3 Farmingdale, New York 11735 Re:Enzo Biochem, Inc. Registration Statement on Form S-3 Filed May 15, 2023 File No. 333-271911 Dear Hamid Erfanian: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Benjamin Richie at 202-551-7857 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Richard Bass
Show Raw Text
United States securities and exchange commission logo
May 22, 2023
Hamid Erfanian
Chief Executive Officer
Enzo Biochem, Inc.
81 Executive Blvd., Suite 3
Farmingdale, New York 11735
Re:Enzo Biochem, Inc.
Registration Statement on Form S-3
Filed May 15, 2023
File No. 333-271911
Dear Hamid Erfanian:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Benjamin Richie at 202-551-7857 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Richard Bass